Millions of Americans walk around every day living undiagnosed with various conditions ranging from metabolic disease, to cardiac illness, to mental health disorders, just to name a few. The overall burden on patient health and outcomes is significant, and if these patients were being properly treated, their quality of life and, in some cases, their life expectancy could be significantly improved. Other patients, despite being properly diagnosed, are still not receiving or completing standard of care treatment.
According to the CDC, in the vaccines space alone, 50,000 adults die each year from vaccine- preventable diseases, while thousands suffer significant health issues. When looking at other therapeutic areas, the numbers are staggering. Not only do lack of diagnosis and treatment according to standards of care have a potential impact on patient outcomes and quality of life, they also place a heavy economic burden on our already strained healthcare ecosystem. The COVID-19 epidemic has worsened the situation with 41% of adults in the US delaying or avoiding medical care.1
At Essence Patient Solutions we are committed to doing our part to help improve the lives of patients and alleviate the significant economic burden being placed on our health care system by developing and executing innovative commercial value-based care solutions for Life Science Companies.
Essence leverages the scale, patient and provider access, and data capabilities of market partners across payer and provider markets to provide our clients with access to over 150M active patients. Our commercial value-based digital health solutions empower patients to be active participants in their health. By identifying and engaging patients through our vast network, Essence Patient Solutions executes programs that have a significant national impact for our clients, allowing for patient segmentation, education, activation, and measurement, at scale.
Essence Patient Solutions offers commercial digital health solutions to partner with you to identify, engage and empower patients and their respective providers.
Targeted immunization patient outreach and activation solution.
Primary care disease patient identification and activation solution.
Our Commercial Solution Capabilities help you identify and engage both target patients and their providers. Learn more about our commercial solution capabilities.
1 Zeisler MÉ, Marynak K, Clarke KE, et al. Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020. MMWR Morb Mortal Wkly Rep 2020;69:1250–1257. DOI: http://dx.doi.org/10.15585/mmwr.mm6936a4.